English | 简体中文 | 繁體中文 | 한국어 | 日本語
Monday, 23 January 2012, 09:00 HKT/SGT
Share:
    

Source: Pharma Regulatory Affairs
National Agency of Drug and Food Control, Indonesia Newly Confirmed Present at 2nd Annual Pharma Regulatory Affairs Asia

SINGAPORE, Jan 23, 2012 - (ACN Newswire) - "Asia regulations keep on changing, in particular in all the established countries like China and Japan. Another change is that many countries don't have regulations at the moment but they are going to have new regulations (e.g. drug-medical device combined product) coming, so they will uniquely register in their country very soon. In the past, you didn't need it. An example of this is India, Hong Kong, Singapore, Malaysia, etc. So there will be two major dynamics that I think companies need to be aware of," said Jack Wong, Regulatory Affairs Director, Johnson and Johnson Medical.

Indeed, like what Jack has mentioned, ensuring regulatory compliance has become one of the biggest challenges for products development in Asia.

Jack Wong will be speaking at the 2nd Annual Pharma Regulatory Affairs Asia conference, which will take place on 25-26 April 2012 in Singapore.

In China, what's the impact of the healthcare system reform on pharma companies?

In Korea, what's the impact of recently IND Regulation changes and what's the next step of regulation updates?

In Vietnam, what is the regulation framework for drug registration and product commercialisation?

In Indonesia, what are the new regulations related to pre-market evaluation?

The 2nd Annual Pharma Regulatory Affairs Asia conference will feature speakers from Thailand FDA, National Agency of Drug and Food Control, Indonesia, DIA, APEC Harmonization Centre, Novartis, AstraZeneca, Johnson & Johnson among the others, and will discuss pharma regulation updates and regulatory compliance in China, India, Korea, Thailand, Vietnam, Indonesia and Philippines.

Drop an email to enquiry@iqpc.com.sg to register for the conference or visit www.pharmaregulatoryaffairsasia.com for the full list of speakers and topics that will be covered at the 2nd Annual Pharma Regulatory Affairs Asia.

Contact:
Bryan Camoens
IQPC Worldwide
Tel: +65-67229406
Email: bryan.camoens@iqpc.com.sg


Topic: Press release summary
Source: Pharma Regulatory Affairs

Sectors: Trade Shows, BioTech
https://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2025 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.

 

Latest Press Releases
TruMerit and NAPNAP Team Up to Develop a Global Micro-credential for Pediatric Nursing Care  
Dec 18, 2025 17:05 HKT/SGT
PropertyGuru Asia Real Estate Summit spotlights PropertyGuru Week 2025 with conversations on 'Trusted Marketplaces and Thriving Communities'  
Dec 18, 2025 09:00 HKT/SGT
1World Online and Culinary Heritage Announce Strategic Partnership and Joint Launches in Europe  
Dec 17, 2025 23:29 HKT/SGT
Anson Resources: Update on Cooperation between Anson and POSCO Holdings for DLE Green River Demonstration Plant  
Dec 17, 2025 07:00 HKT/SGT
AWM Wraps Up 2025 with Multiple Surf Venue Grand Openings  
Dec 16, 2025 23:05 HKT/SGT
Eastman, AstraZeneca, Kraft Heinz, and P&G Recognized with OMP Supply Chain Awards  
Dec 16, 2025 22:00 HKT/SGT
Doubleview Gold Corp Extends Mineralization East of 2024 Conceptual Pit and Identifies Deeper Porphyry Indicators at Hat Project by Drilling 992m of 0.29% CuEq in Hole H101  
Dec 16, 2025 20:29 HKT/SGT
The U.S. Polo Assn. Palm Beaches Marathon Celebrates Record-Breaking Weekend in West Palm Beach, Florida  
Dec 16, 2025 20:00 HKT/SGT
TASPEN Enhances Digital Pension Services with Mobile Biometric Authentication  
Dec 16, 2025 17:00 HKT/SGT
Developers and designers of tomorrow's cities triumph at the 20th PropertyGuru Asia Property Awards Grand Final  
Dec 16, 2025 17:00 HKT/SGT
More Press release >>
 Events:
More events >>
Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575